599 results on '"Sharifi, Iraj"'
Search Results
2. Global Dilemma and Needs Assessment Toward Achieving Sustainable Development Goals in Controlling Leishmaniasis
3. Cutaneous Leishmaniasis Hampers COVID-19: A Controlled Cross-Sectional Study in High-Burden Endemic Areas of Iran
4. Monitoring of airborne fungi during the second wave of COVID-19 in selected wards of the referral university hospital in southeastern Iran
5. Antileishmanial Effects of Bunium Persicum Crude Extract, Essential Oil, and Cuminaldehyde on Leishmania Major: In Silico and In Vitro Properties
6. The potential effect of silver nanoparticles synthesized with Coffea arabica green seeds on Leishmania major proliferation, cytotoxicity activity, and cytokines expression level
7. A prospective longitudinal study on the elimination trend of rural cutaneous leishmaniasis in southeastern Iran: Climate change, population displacement, and agricultural transition from 1991 to 2021
8. Aberrant expression of SOCS impairs the anti-leishmanial immune response
9. The Potential Role of Lipopeptide Biosurfactant Generated by Acinetobacter junii B6 on Leishmania Tropica: The Synergy of Lipopeptide Biosurfactant and Glucantime
10. Comparison of cytotoxicity of Miltefosine and its niosomal form on chick embryo model
11. Exploring mesoporous silica nanoparticles as oral insulin carriers: In-silico and in vivo evaluation
12. Antileishmanial effects and drugability characteristics of a heterocyclic copper complex: An in silico, in vitro and molecular study
13. Synthesis and physicochemical characterization of Zn–Al layered double hydroxides (LDHs) as a delivery system for amphotericin B: In vitro and in silico antileishmanial study
14. Poor adherence is a major barrier to the proper treatment of cutaneous leishmaniasis: A case-control field assessment in Iran
15. Bioinformatics evaluation of anticancer properties of GP63 protein-derived peptides on MMP2 protein of melanoma cancer
16. Application of Rodenticides for the Control of Zoonotic Cutaneous Leishmaniasis in Iran: A Systematic Review of the Literature
17. Baseline susceptibility of a wild strain of main vectors of leishmaniasis to WHO-recommended insecticides in southeastern Iran
18. Preparation and evaluation of physicochemical properties and anti-leishmanial activity of zirconium/tioxolone niosomes against Leishmania major
19. Prophylactic effect of cutaneous leishmaniasis against COVID-19: a case-control field assessment
20. Blood transcriptional profiles distinguish different clinical stages of cutaneous leishmaniasis in humans
21. A novel rapid LAMP test for identification of cutaneous leishmaniasis: An evaluation and comparative analysis of three molecular methods
22. The expression of PD-1 and its ligands increases in Leishmania infection and its blockade reduces the parasite burden
23. Anti-leishmanial activity of Avicennia marina (Avicenniaceae family) leaves hydroalcoholic extract and its possible cellular mechanisms
24. Antiproliferative properties of Turmerone on Leishmania major: Modes of action confirmed by antioxidative and immunomodulatory roles
25. The impact of diabetes on cutaneous leishmaniasis: a case–control field assessment
26. A Systematic Review of Curcumin and its Derivatives as Valuable Sources of Antileishmanial Agents
27. In vitro and in vivo therapeutic potentials of 6-gingerol in combination with amphotericin B for treatment of Leishmania major infection: Powerful synergistic and multifunctional effects
28. Therapeutic effects of the as-synthesized polylactic acid/chitosan nanofibers decorated with amphotricin B for in vitro treatment of Leishmaniasis
29. PD-1/PD-L1 and PD-1/PD-L2 axes-targeted anti-leishmanial therapy
30. Barium carbonate nanostructures: Biosynthesis and their biomedical applications
31. The Effect of Naja naja oxiana Snake Venom Against Leishmania tropica Confirmed by Advanced Assays
32. The assessment of apoptosis, toxicity effects and anti-leishmanial study of Chitosan/CdO core-shell nanoparticles, eco-friendly synthesis and evaluation
33. The potential role and apoptotic profile of three medicinal plant extracts on Leishmania tropica by MTT assay, macrophage model and flow cytometry analysis
34. Linguatula serrata in cattle in southeastern Iran: Epidemiological, histopathological and phylogenetic profile and its zoonotic importance
35. Establishment and mass breeding of Phlebotomus papatasi (Diptera: Pshychodidae) in Orzouieh county in Kerman Province, Southeast of Iran.
36. Partridge and embryonated partridge egg as new preclinical models for candidiasis
37. A long-lasting emerging epidemic of anthroponotic cutaneous leishmaniasis in southeastern Iran: population movement and peri-urban settlements as a major risk factor
38. Geographical and climatic risk factors of cutaneous leishmaniasis in the hyper-endemic focus of Bam County in southeast Iran
39. Visceral Leishmaniasis in Iran: An Update on Epidemiological Features from 2013 to 2022
40. In silico and in vitro potentials of crocin and amphotericin B on Leishmania major: Multiple synergistic mechanisms of actions
41. Murine cathelicidin: as a host defensive response against Leishmania major infection
42. Detection of malaria with light microscopy and Nested polymerase chain reaction (Nested PCR) methods in peripheral blood expansions and investigation of the genetic diversity of Plasmodium species by 18S rRNA gene in Southeast of Iran
43. Prevalence and Molecular Subtyping of Blastocystis from Patients with Irritable Bowel Syndrome, Inflammatory Bowel Disease and Chronic Urticaria in Iran
44. Serum 25-hydroxyvitamin D level and vitamin D receptor (VDR) polymorphisms in patients infected with Leishmania tropica: a case control study
45. Antileishmanial activity and immune modulatory effects of benzoxonium chloride and its entrapped forms in niosome on Leishmania tropica
46. Niosomal formulation of amphotericin B alone and in combination with glucantime: In vitro and in vivo leishmanicidal effects
47. Toxico-pathological effects of meglumine antimoniate on human umbilical vein endothelial cells
48. A single-group trial of end-stage patients with anthroponotic cutaneous leishmaniasis: Levamisole in combination with Glucantime in field and laboratory models
49. Differential expression of TLRs 2, 4, 9, iNOS and TNF-α and arginase activity in peripheral blood monocytes from glucantime unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis caused by Leishmania tropica
50. Rectangular shaped zinc oxide nanoparticles: Green synthesis by Stevia and its biomedical efficiency
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.